Rani Hasan, MD
Interventional Cardiology · Baltimore, MDNPI 1205999463
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 79.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $10,503 and has fallen 57.9% since, to $4,421 in 2025.
Across 135 payments — averaging $164.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- Abbott$2K
- Edwards Lifesciences$2K
- Boston Scientific$225
- Biotronik Inc.$142
- Johnson & Johnson$34
- plus $59 from 3 others
Across 28 payments — averaging $12,559 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$254K
- Medtronic$97K
What the payments were for
- Speaking & faculty fees$4,95022%
- Travel & lodging$12,28855%
- Food & beverage$4,95922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $17,688 |
| Abbott | 36 | $2,341 |
| Edwards Lifesciences | 12 | $1,709 |
| Boston Scientific | 6 | $225 |
| Biotronik Inc. | 1 | $142 |
| Johnson & Johnson | 2 | $34 |
| Biosense Webster, Inc. | 1 | $25 |
| Chiesi USA, Inc. | 1 | $19 |
| Terumo Medical Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$10,113
- COREVALVE EVOLUT R$5,723
- EVOQUE$378
- MitraClip$146
- OPTIS$126
- Dragonfly OCT$116
- Watchman$113
- APOLLOTM$108
- Mitra Clip system$107
How this compares
$22,197 in reported general payments places this provider in the 75th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $18,283 |
| JardianceEmpagliflozin | 14 | $17,945 |
| Metoprolol Succinate | 36 | $707 |
| Losartan Potassium | 12 | $156 |
| Atorvastatin Calcium | 17 | $139 |
| Furosemide | 12 | $49 |
| Amoxicillin | 16 | $43 |
| Spironolactone | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Baltimore
- Aloke FinnBaltimore$575K
- John WangBaltimore$138K
- Diljon ChahalBaltimore$78K
- Jon ResarBaltimore$40K
- Faisal RahmanBaltimore$36K
- Matthew VossBaltimore$33K
- Hooman BakhshiBaltimore$32K
- Daniel AmbinderBaltimore$32K
- Ajar KocharBaltimore$22K
- Hani AlkhatibBaltimore$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.